(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1314687 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SERPINB1 mRNA CTD PMID:22079256 (S)-nicotine increases expression ISO RGD:1314688 6480464 Nicotine results in increased expression of SERPINB1A mRNA CTD PMID:21955143 17alpha-ethynylestradiol increases expression ISO RGD:1314688 6480464 Ethinyl Estradiol results in increased expression of SERPINB1A mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of SERPINB1A mRNA CTD PMID:29097150 17alpha-ethynylestradiol multiple interactions ISO RGD:1314688 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SERPINB1A mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1314687 6480464 Estradiol results in decreased expression of SERPINB1 mRNA CTD PMID:23019147 , PMID:25321415 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314688 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SERPINB1A mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314688 6480464 Tetrachlorodibenzodioxin results in decreased expression of SERPINB1A mRNA CTD PMID:15034205 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314688 6480464 Tetrachlorodibenzodioxin affects the expression of SERPINB1A mRNA CTD PMID:21570461 , PMID:26377647 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:1314687 6480464 2 more ... CTD PMID:17547211 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1314688 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of SERPINB1A mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol decreases expression ISO RGD:1314688 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of SERPINB1A mRNA CTD PMID:30951980 5-(N,N-hexamethylene)amiloride multiple interactions ISO RGD:1314687 6480464 5-(N, N-hexamethylene)amiloride results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form CTD PMID:25447644 acetylsalicylic acid decreases expression ISO RGD:1314687 6480464 Aspirin results in decreased expression of SERPINB1 mRNA CTD PMID:14976132 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SERPINB1A mRNA CTD PMID:28959563 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SERPINB1A mRNA CTD PMID:23630614 , PMID:25378103 all-trans-retinoic acid affects localization ISO RGD:1314687 6480464 Tretinoin affects the localization of SERPINB1 protein CTD PMID:16569592 all-trans-retinoic acid increases expression ISO RGD:1314687 6480464 Tretinoin results in increased expression of SERPINB1 mRNA CTD PMID:15498508 more ... all-trans-retinoic acid multiple interactions ISO RGD:1314687 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of SERPINB1 mRNA CTD PMID:15894607 amiodarone increases expression ISO RGD:1314688 6480464 Amiodarone results in increased expression of SERPINB1A mRNA CTD PMID:24535564 antimony(0) decreases expression ISO RGD:1314687 6480464 Antimony results in decreased expression of SERPINB1 mRNA CTD PMID:17547211 antirheumatic drug decreases expression ISO RGD:1314687 6480464 Antirheumatic Agents results in decreased expression of SERPINB1 mRNA CTD PMID:24449571 arsenous acid increases expression ISO RGD:1314687 6480464 Arsenic Trioxide results in increased expression of SERPINB1 mRNA CTD PMID:15761015 more ... arsenous acid multiple interactions ISO RGD:1314687 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SERPINB1 mRNA CTD PMID:15894607 belinostat decreases expression ISO RGD:1314687 6480464 belinostat results in decreased expression of SERPINB1 mRNA CTD PMID:27188386 benzo[a]pyrene increases expression ISO RGD:1314687 6480464 Benzo(a)pyrene results in increased expression of SERPINB1 mRNA CTD PMID:22316170 benzo[a]pyrene decreases expression ISO RGD:1314687 6480464 Benzo(a)pyrene results in decreased expression of SERPINB1 mRNA CTD PMID:26238291 benzo[a]pyrene decreases expression ISO RGD:1314688 6480464 Benzo(a)pyrene results in decreased expression of SERPINB1A mRNA CTD PMID:15034205 , PMID:22228805 benzo[a]pyrene multiple interactions ISO RGD:1314688 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB1A mRNA, AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SERPINB1A mRNA] CTD PMID:22228805 , PMID:27858113 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1314687 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene increases expression ISO RGD:1314688 6480464 benzo(b)fluoranthene results in increased expression of SERPINB1A mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:1314688 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB1A mRNA CTD PMID:27858113 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SERPINB1A mRNA CTD PMID:18164116 bilirubin IXalpha decreases expression ISO RGD:1314687 6480464 Bilirubin results in decreased expression of SERPINB1A mRNA CTD PMID:20196124 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SERPINB1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1314688 6480464 bisphenol A results in decreased expression of SERPINB1A mRNA CTD PMID:30951980 bisphenol F decreases expression ISO RGD:1314688 6480464 bisphenol F results in decreased expression of SERPINB1A mRNA CTD PMID:30951980 butan-1-ol multiple interactions ISO RGD:1314687 6480464 [[Gasoline co-treated with 1-Butanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SERPINB1 mRNA CTD PMID:29432896 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of SERPINB1A mRNA CTD PMID:17327700 cadmium atom decreases expression ISO RGD:1314687 6480464 Cadmium results in decreased expression of SERPINB1 mRNA CTD PMID:17547211 cadmium dichloride decreases expression ISO RGD:1314687 6480464 Cadmium Chloride results in decreased expression of SERPINB1 mRNA CTD PMID:17547211 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SERPINB1A mRNA CTD PMID:17327700 calcitriol multiple interactions ISO RGD:1314687 6480464 Ketoconazole promotes the reaction [Calcitriol results in increased expression of SERPINB1 mRNA] CTD PMID:26485663 calcitriol increases expression ISO RGD:1314687 6480464 Calcitriol results in increased expression of SERPINB1 mRNA CTD PMID:15951637 more ... carbon nanotube decreases expression ISO RGD:1314688 6480464 Nanotubes, Carbon analog results in decreased expression of SERPINB1A mRNA, Nanotubes, Carbon results in decreased expression of SERPINB1A mRNA CTD PMID:25554681 , PMID:25620056 carmustine affects response to substance ISO RGD:1314687 6480464 SERPINB1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 chromium atom decreases expression ISO RGD:1314687 6480464 Chromium results in decreased expression of SERPINB1 mRNA CTD PMID:17547211 chrysene multiple interactions ISO RGD:1314688 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB1A mRNA CTD PMID:27858113 copper atom decreases expression EXP 6480464 Copper results in decreased expression of SERPINB1A mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of SERPINB1A mRNA CTD PMID:30556269 cortisol multiple interactions EXP 6480464 Hydrocortisone results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1A protein modified form CTD PMID:25447644 cortisol multiple interactions ISO RGD:1314687 6480464 Hydrocortisone results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form CTD PMID:25447644 coumestrol decreases expression ISO RGD:1314687 6480464 Coumestrol results in decreased expression of SERPINB1 mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:1314687 6480464 Cyclosporine results in increased expression of SERPINB1 mRNA CTD PMID:25562108 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of SERPINB1A mRNA CTD PMID:20032058 dexamethasone multiple interactions ISO RGD:1314687 6480464 Dexamethasone results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form CTD PMID:25447644 dexamethasone multiple interactions EXP 6480464 Dexamethasone results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1A protein modified form, Testosterone inhibits the reaction [Dexamethasone results in decreased expression of SERPINB1A mRNA] CTD PMID:20032058 , PMID:25447644 dexamethasone phosphate multiple interactions EXP 6480464 dexamethasone 21-phosphate results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1A protein modified form CTD PMID:25447644 dexamethasone phosphate multiple interactions ISO RGD:1314687 6480464 dexamethasone 21-phosphate results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form CTD PMID:25447644 diarsenic trioxide multiple interactions ISO RGD:1314687 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SERPINB1 mRNA CTD PMID:15894607 diarsenic trioxide increases expression ISO RGD:1314687 6480464 Arsenic Trioxide results in increased expression of SERPINB1 mRNA CTD PMID:15761015 more ... dibenz[a,h]anthracene increases expression ISO RGD:1314688 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:1314688 6480464 Dibutyl Phthalate results in decreased expression of SERPINB1A mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:1314687 6480464 dicrotophos results in decreased expression of SERPINB1 mRNA CTD PMID:28302478 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO RGD:1314687 6480464 Antimony Potassium Tartrate results in decreased expression of SERPINB1 mRNA CTD PMID:17547211 diuron decreases expression EXP 6480464 Diuron metabolite results in decreased expression of SERPINB1A mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:1314687 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1314687 6480464 Doxorubicin results in increased expression of SERPINB1 mRNA CTD PMID:29803840 ethanol increases expression ISO RGD:1314688 6480464 Ethanol results in increased expression of SERPINB1A mRNA CTD PMID:21955143 ethanol affects expression ISO RGD:1314688 6480464 Ethanol affects the expression of SERPINB1A mRNA CTD PMID:30319688 ferric oxide decreases expression ISO RGD:1314688 6480464 ferric oxide analog results in decreased expression of SERPINB1A mRNA CTD PMID:24525745 flavone increases expression ISO RGD:1314687 6480464 flavone results in increased expression of SERPINB1 protein CTD PMID:14750173 formaldehyde increases expression ISO RGD:1314687 6480464 Formaldehyde results in increased expression of SERPINB1 mRNA CTD PMID:27664576 furan decreases expression ISO RGD:1314688 6480464 furan results in decreased expression of SERPINB1A mRNA CTD PMID:24183702 furan increases expression EXP 6480464 furan results in increased expression of SERPINB1A mRNA CTD PMID:27387713 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SERPINB1A mRNA CTD PMID:22061828 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SERPINB1A protein CTD PMID:22061828 hydrogen peroxide affects expression ISO RGD:1314687 6480464 Hydrogen Peroxide affects the expression of SERPINB1 mRNA CTD PMID:20044591 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SERPINB1A mRNA CTD PMID:21396975 isobutanol multiple interactions ISO RGD:1314687 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SERPINB1 mRNA CTD PMID:29432896 ketamine increases expression EXP 6480464 Ketamine results in increased expression of SERPINB1A mRNA CTD PMID:20080153 ketoconazole multiple interactions ISO RGD:1314687 6480464 Ketoconazole promotes the reaction [Calcitriol results in increased expression of SERPINB1 mRNA] CTD PMID:26485663 menadione affects expression ISO RGD:1314687 6480464 Vitamin K 3 affects the expression of SERPINB1 mRNA CTD PMID:20044591 mercury atom decreases expression ISO RGD:1314687 6480464 Mercury results in decreased expression of SERPINB1 mRNA CTD PMID:17547211 mercury dibromide decreases expression ISO RGD:1314687 6480464 mercuric bromide results in decreased expression of SERPINB1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1314687 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA CTD PMID:27188386 mercury(0) decreases expression ISO RGD:1314687 6480464 Mercury results in decreased expression of SERPINB1 mRNA CTD PMID:17547211 methotrexate increases expression ISO RGD:1314687 6480464 Methotrexate results in increased expression of SERPINB1 mRNA CTD PMID:21678067 methylmercury chloride decreases expression ISO RGD:1314687 6480464 methylmercuric chloride results in decreased expression of SERPINB1 mRNA CTD PMID:23179753 more ... morphine decreases expression ISO RGD:1314688 6480464 Morphine results in decreased expression of SERPINB1A mRNA CTD PMID:21955143 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of SERPINB1A mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SERPINB1A mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SERPINB1A mRNA CTD PMID:18164116 , PMID:28943392 N-nitrosodimethylamine decreases expression ISO RGD:1314687 6480464 Dimethylnitrosamine results in decreased expression of SERPINB1 mRNA CTD PMID:17547211 nickel atom increases expression ISO RGD:1314687 6480464 Nickel results in increased expression of SERPINB1 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride decreases expression ISO RGD:1314687 6480464 nickel chloride results in decreased expression of SERPINB1 mRNA CTD PMID:17547211 nicotine increases expression ISO RGD:1314688 6480464 Nicotine results in increased expression of SERPINB1A mRNA CTD PMID:21955143 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SERPINB1A mRNA CTD PMID:25729387 p-chloromercuribenzoic acid decreases expression ISO RGD:1314687 6480464 p-Chloromercuribenzoic Acid results in decreased expression of SERPINB1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1314687 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:1314688 6480464 Acetaminophen affects the expression of SERPINB1A mRNA CTD PMID:17562736 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of SERPINB1A mRNA CTD PMID:28511854 phenobarbital increases expression ISO RGD:1314688 6480464 Phenobarbital results in increased expression of SERPINB1A mRNA CTD PMID:19270015 more ... phenobarbital affects expression ISO RGD:1314688 6480464 Phenobarbital affects the expression of SERPINB1A mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:1314687 6480464 Phenylmercuric Acetate results in decreased expression of SERPINB1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1314687 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1314688 6480464 pirinixic acid results in increased expression of SERPINB1A mRNA CTD PMID:20813756 , PMID:23811191 potassium chromate multiple interactions ISO RGD:1314687 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SERPINB1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1314687 6480464 potassium chromate(VI) results in decreased expression of SERPINB1 mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO RGD:1314687 6480464 Potassium Dichromate results in decreased expression of SERPINB1 mRNA CTD PMID:17547211 potassium dichromate increases expression ISO RGD:1314687 6480464 Potassium Dichromate results in increased expression of SERPINB1 protein CTD PMID:23718831 pravastatin decreases expression ISO RGD:1314688 6480464 Pravastatin results in decreased expression of SERPINB1A mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of SERPINB1A mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1314688 6480464 Pregnenolone Carbonitrile results in decreased expression of SERPINB1A mRNA CTD PMID:27413110 progesterone increases expression ISO RGD:1314688 6480464 Progesterone results in increased expression of SERPINB1A mRNA CTD PMID:22238285 quercetin decreases expression ISO RGD:1314687 6480464 Quercetin results in decreased expression of SERPINB1 mRNA CTD PMID:21632981 quercetin increases expression ISO RGD:1314687 6480464 Quercetin results in increased expression of SERPINB1 protein CTD PMID:14750173 quinoline increases expression ISO RGD:1314687 6480464 quinoline analog results in increased expression of SERPINB1 protein CTD PMID:18645022 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of SERPINB1A mRNA CTD PMID:25905778 rifampicin multiple interactions ISO RGD:1314687 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of SERPINB1 mRNA CTD PMID:21127053 SB 431542 multiple interactions ISO RGD:1314687 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1314687 6480464 Silicon Dioxide analog results in decreased expression of SERPINB1 mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:1314688 6480464 Silver results in decreased expression of SERPINB1A mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1314688 6480464 Silver results in decreased expression of SERPINB1A mRNA CTD PMID:27131904 sodium arsenate decreases expression ISO RGD:1314688 6480464 sodium arsenate results in decreased expression of SERPINB1A mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:1314687 6480464 sodium arsenite results in decreased expression of SERPINB1 mRNA, sodium arsenite results in decreased expression of SERPINB1 protein CTD PMID:12727804 , PMID:29207610 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of SERPINB1A protein CTD PMID:29653260 Soman increases expression EXP 6480464 Soman results in increased expression of SERPINB1A mRNA CTD PMID:19281266 sulindac increases expression ISO RGD:1314687 6480464 Sulindac results in increased expression of SERPINB1 mRNA CTD PMID:11507085 tamibarotene increases expression ISO RGD:1314687 6480464 tamibarotene results in increased expression of SERPINB1 mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:1314688 6480464 Tamoxifen affects the expression of SERPINB1A mRNA CTD PMID:20937368 temozolomide affects response to substance ISO RGD:1314687 6480464 SERPINB1 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 tert-butyl hydroperoxide decreases expression ISO RGD:1314687 6480464 tert-Butylhydroperoxide results in decreased expression of SERPINB1 mRNA CTD PMID:15336504 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of SERPINB1A mRNA] CTD PMID:20032058 testosterone decreases expression ISO RGD:1314688 6480464 Testosterone results in decreased expression of SERPINB1A mRNA CTD PMID:20403060 , PMID:20844152 tetraphene multiple interactions ISO RGD:1314688 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB1A mRNA CTD PMID:27858113 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SERPINB1A mRNA CTD PMID:28943392 titanium dioxide decreases expression ISO RGD:1314688 6480464 titanium dioxide results in decreased expression of SERPINB1A mRNA CTD PMID:23409001 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SERPINB1A mRNA CTD PMID:25729387 topotecan affects response to substance ISO RGD:1314687 6480464 SERPINB1 protein affects the susceptibility to Topotecan CTD PMID:16217747 triamcinolone acetonide multiple interactions EXP 6480464 Triamcinolone Acetonide results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1A protein modified form CTD PMID:25447644 triamcinolone acetonide multiple interactions ISO RGD:1314687 6480464 Triamcinolone Acetonide results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form CTD PMID:25447644 trichloroethene increases expression ISO RGD:1314687 6480464 Trichloroethylene results in increased expression of SERPINB1 mRNA, Trichloroethylene results in increased expression of SERPINB1 protein CTD PMID:19109764 troglitazone increases expression ISO RGD:1314688 6480464 troglitazone results in increased expression of SERPINB1 mRNA CTD PMID:28973697 valproic acid increases expression ISO RGD:1314688 6480464 Valproic Acid results in increased expression of SERPINB1A mRNA CTD PMID:24535564 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SERPINB1A mRNA CTD PMID:29427782 valproic acid multiple interactions ISO RGD:1314687 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1314687 6480464 Valproic Acid results in decreased expression of SERPINB1 mRNA CTD PMID:26272509 valproic acid decreases expression ISO RGD:1314688 6480464 Valproic Acid results in decreased expression of SERPINB1A mRNA CTD PMID:24896083 valproic acid affects expression ISO RGD:1314687 6480464 Valproic Acid affects the expression of SERPINB1 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of SERPINB1A mRNA CTD PMID:19015723 
Gene Ontology Annotations
